Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

199 results about "Dermatological disorders" patented technology

N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use

Compositions comprising N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl compounds are useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and / or extrinsic aging, as well as changes or damage caused by extrinsic factors. N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl composition may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Owner:TRISTRATA TECH

Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith

A method for preventing or treating dermatological disorders and dermatological disorder-related complications in a subject involves a monotherapy with a Cox-2 inhibitor or a combination therapy with a Cox-2 inhibitor and a dermatological treatment agent. Also described are therapeutic compositions comprising a Cox-2 inhibitor and a dermatological treatment agent. Pharmaceutical compositions and kits for implementing the present method are also described.
Owner:PHARMACIA CORP

Fatty acid pharmaceutical foam

The present invention provides a foamable composition comprising water and an organic solvent, wherein the organic solvent comprises a fatty acid. The composition may further comprise a pharmaceutically active agent. The composition of the invention is also useful for the treatment of a dermatological disorder in a mammal by the topical administration of the composition.
Owner:STIEFEL RESEARCH AUSTRALIA PTY LTD

Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections

The present disclosure provides a device having a casing with a barrier surface and a contact surface and a composition in the casing having a nitric oxide precursor and an isolated enzyme or live cell expressing an endogenous enzyme, for converting the nitric oxide gas precursor to nitric oxide gas or having activity on a substrate that produces a catalyst that causes the conversion of the nitric oxide gas precursor to nitric oxide gas. The present disclosure also provides methods and uses for treating wounds, microbial infections and dermatological disorders and for preserving meat products.
Owner:MICROPHARMA

Composition and method for topical treatment of tar-responsive dermatological disorders

InactiveUS20070207222A1Reduced and no stickinessReduced and no and stainingAntibacterial agentsBiocideWaxDermatological disorders
The present invention relates to a composition including a wax and a therapeutically effective amount of tar for topical treatment of a tar-responsive dermatological disorder, the composition being in liquid or light gel form when at a temperature selected from room temperature and a temperature of skin of a mammal upon application of the composition to the skin of the mammal. The invention also relates to a method of treating a tar-responsive dermatological disorder by topically applying the composition to skin of a mammal, preferably a human, that is involved with the disorder.
Owner:TRISTRATA TECH

Oligosaccharide aldonic acids and their topical use

Compositions comprising oligosaccharide aldonic acids are useful for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and / or extrinsic aging, as well as with changes or damage caused by extrinsic factors; general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa; for general oral care, as well as treatment and prevention of oral and gum diseases; and for wound healing of the skin. Compositions comprising oligosaccharide aldonic acids may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Owner:YU RUEY J +1

Sprayable compositions comprising a combination of pharmaceutical actives and an oily phase

InactiveUS20050281749A1Good acceptability and toleranceChemically stableBiocideAerosol deliveryDermatological disordersOil phase
Sprayable, anhydrous and physically / chemically stable dermatological / pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticoid, notably dissolved clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably dissolved calcitriol; and c) an oily phase which comprises one or more oils; formulated into d), a sprayable and topically applicable, dermatologically / pharmaceutically acceptable vehicle therefor.
Owner:GALDERMA SA

Antibodies to Dkk-1

The present invention provides antibodies and immunologically functional fragments thereof that specifically bind Dkk-1 polypeptides. The subject antibodies and fragments bind with high affinity to a conformational epitope located in the carboxy region of the Dkk-1 protein. Methods for preparing such antibodies or fragments thereof as well as physiologically acceptable compositions containing the antibodies or fragments are also provided. Use of the antibodies and fragments to treat various diseases including bone disorders, inflammatory diseases, neurological diseases, ocular diseases, renal diseases, pulmonary diseases and skin diseases are also disclosed.
Owner:AMGEN INC

Method and apparatus for treating the body

A therapeutic method in which plural points on the body are stimulated by light of different wavelengths emitted from wands, probes or other applicators under the control of a central microprocessor. The microprocessor executes program instructions to produce light at each applicator whose intensity, frequency, duration and pulsation accord with protocols which are automatically selected depending on the portion of the body being treated. The protocols can be manually overridden by the therapist, in which case the changed parameters are stored in memory. The apparatus is particularly useful in performing traditional therapeutic methods to treat internal disorders, substance abuse, pediatric and podiatric problems and disorders of the ear, nose, throat, as well as musculoskeletal, neurological or dermatological disorders.
Owner:MAC BEAM

Compositions comprising phenyl-glycine derivatives

The invention relates to compositions and methods useful for treating a variety of cosmetic conditions and dermatological disorders, where the composition includes a phenyl glycine derivative represented by the following formula:wherein, R1 and R2 are independently H, I, F, Cl, Br, OH, SH, NH2, NHNH2, alkyl, aralkyl, alkoxy, acetoxy, acyloxy group having 1 to 9 carbon atoms, and being attached at the 2, 3 or 4 position of the phenyl group, whereby when R1 and / or R2 are OH, SH, NH2, they may be acetylated or acylated with 1 to 9 carbon atoms; R3 is H, formyl, acetyl, propanoyl, acyl, alkyl, aralkyl or an aryl group having 1 to 9 carbon atoms; R4 is OH, NH2, NHOH, NHNH2, or OR; where R is an alkyl, aralkyl or aryl group having 1 to 9 carbon atoms; the H attached to any carbon or nitrogen atom may be substituted by I, F, Cl, Br, OH, SH, NH2, NHNH2, an alkyl, aralkyl, alkoxy or acyl group having 1 to 9 carbon atoms. Phenyl-glycine and its derivatives may be present as isomeric D or L, non-isomeric or racemic DL, as a free acid, salt, lactone, amide or ester form.
Owner:YU RUEY J +1

Hair care composition

Hair care composition comprising from about 0.1% to about 20% of a sulfopropyl(meth)acrylate compound, an alpha methylene lactone, or a mixture thereof, wherein the sulfopropyl(meth)acrylate compound and the alpha methylene lactone each have a molecular weight of less than 500 grams / mole; and a dermatologically acceptable carrier.
Owner:THE PROCTER & GAMBLE COMPANY

Oligosaccharide aldonic acids and their topical use

Compositions comprising oligosaccharide aldonic acids are useful for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and / or extrinsic aging, as well as with changes or damage caused by extrinsic factors; general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa; for general oral care, as well as treatment and prevention of oral and gum diseases; and for wound healing of the skin. Compositions comprising oligosaccharide aldonic acids may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Owner:YU RUEY J +1

Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists

In one aspect, the present invention relates to use of an ACE inhibitor and / or angiotensin II receptor antagonist for the preparation of a medicament for the treatment of a dermatological disorder, particularly by topical application of said ACE inhibitor and / or angiotensin II receptor antagonist. The present invention also provides cosmetic methods for improving and / or maintaining the skin tone of an individual suffering from, or at risk of suffering from, a dermatological disorder, said method comprising contacting the skin of said individual with an ACE inhibitor and / or angiotensin II receptor antagonist.
Owner:ACE APS

Skin treatment compositions and methods

A skin treatment composition or cosmetic product comprising a) two or more active components, namely, at least one dermatological acid and at least one meroterpene and b) a dermatologically acceptable carrier.
Owner:SYTHEON

Sprayable compositions comprising a combination of pharmaceutical active ingredients, an alcohol phase and an oily phase

Sprayable, anhydrous and physically / chemically stable dermatological / pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticoid, notably dissolved clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably dissolved calcitriol; and c) an alcohol phase; and d) an oily phase which comprises one or more oils; formulated into e), a sprayable and topically applicable, dermatologically / pharmaceutically acceptable vehicle therefor.
Owner:GALDERMA SA

WTA neural network based on memristor array and application thereof

The present invention belongs to the technical field of a neural network and relates to a WTA neural network based on a memristor array and application thereof. The WTA neural network and application thereof, namely a classifier model, are achieved by a design of the memristor array, thereby proposing a classification identification method that can be used for classifying a dermatology feature. the WTA model consists of a memristor, a MOSFET, a capacitor, a resistor and a power supply. On this basis, the classifier based on memristor array WTA neural network is exported. The purpose of the WTA neural network based on the memristor array and application thereof is to achieve the WTA neural network and theclassifier thereof by the memristor, and to explore the application of the memristor in the neural network and medical decision thereof. Compared to the conventional WTA neural network, the classifier designed by the memristor array in the present invention has excellent properties, and can be applied to the field of medical disease classification and the like.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA

Skin care composition for dermatological disorders

InactiveUS20070190175A1Easy to synthesizeDecrease superficial wrinkleBiocideCosmetic preparationsWrinkle skinSkin texture
A topical skin care composition is provided to improve skin texture, diminish fine lines and wrinkles and decrease the appearance of hyper-pigmented areas. In addition, another embodiment of the skin care composition can be used to treat burns, insect bites and diminish the pain and scarring caused by such injuries.
Owner:TASKER PRODS IP HLDG CORP

Compositions comprising phenyl-glycine derivatives

The invention relates to compositions and methods useful for treating a variety of cosmetic conditions and dermatological disorders, where the composition includes a phenyl glycine derivative represented by the following formula: wherein, R1 and R2 are independently H, I, F, Cl, Br, OH, SH, NH2, NHNH2, alkyl, aralkyl, alkoxy, acetoxy, acyloxy group having 1 to 9 carbon atoms, and being attached at the 2, 3 or 4 position of the phenyl group, whereby when R1 and / or R2 are OH, SH, NH2, they may be acetylated or acylated with 1 to 9 carbon atoms; R3 is H, formyl, acetyl, propanoyl, acyl, alkyl, aralkyl or an aryl group having 1 to 9 carbon atoms; R4 is OH, NH2, NHOH, NHNH2, or OR; where R is an alkyl, aralkyl or aryl group having 1 to 9 carbon atoms; the H attached to any carbon or nitrogen atom may be substituted by I, F, Cl, Br, OH, SH, NH2, NHNH2, an alkyl, aralkyl, alkoxy or acyl group having 1 to 9 carbon atoms. Phenyl-glycine and its derivatives may be present as isomeric D or L, non-isomeric or racemic DL, as a free acid, salt, lactone, amide or ester form.
Owner:YU RUEY J +1

Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema

Described herein are compositions, kits, and methods for the treatment of atopic dermatitis and related dermatological disorders. The invention encompasses a two-step method of treating a condition, wherein the first step involves applying an inventive bleach composition to the skin, and the second step involves applying an inventive barrier repair composition to the skin.
Owner:PRECISION DERMATOLOGY

Methods of treating dermatological disorders or conditions

This invention is directed to the use of TOFA in the treatment of acne and other dermatological disorders. This invention is also directed to pharmaceutical compositions comprising TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
Owner:DERMIRA CANADA

Nanoparticle Compositions Providing Enhanced Color for Cosmetic Formulations

InactiveUS20140030300A1High chromaAlter the appearance of a biological surfaceCosmetic preparationsMake-upOptical propertyNanoparticle
The present invention relates to cosmetic, dermatological, and pharmaceutical compositions that deliver, in an acceptable vehicle or carrier comprising a film former or wax and an effective amount of nanoparticles and one or more pigments and methods for improving the appearance of a biological surface by altering the optical properties of the biological surface. The compositions of the invention enhance color and may be topically applied to the biological surface in an amount effective in improving the aesthetic and natural appearance of the biological surface.
Owner:AVON PROD INC

Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging

A composition comprising an amphoteric or pseudo-amphoteric agent and a polyhydroxy alpha hydroxyacid existing as a free acid, lactone, or salt, and isomeric or non-isomeric forms thereof is provided. The amphoteric or pseudo-amphoteric agent can be selected from amino acids, dipeptides, aminoaldonic acid, aminouronic acid, lauryl aminoproplyglycine, aminoaldaric acid, neuraminic acid desulfated heparin, deacetylated hyaluronic acid, hyalobiuronic acid, chondrosine, deacetylated chondroitin, creatine, creatinine, hydroxyproline, homocysteine, homocystine, homoserine, ornithine, citrulline, phosphatidylserine, and sphingomyelin. The composition may contain other additives, including cosmetic or pharmaceutical agents for topical treatment of dermatological disorders.
Owner:TRISTRATA TECH

Nanoemulsion containing nonionic polymers, and its uses

These objects and others may be accomplished with the present invention, the first embodiment of which provides an oil-in-water nanoemulsion, which includes: an oily phase dispersed in an aqueous phase; (i) at least one amphiphilic lipid selected from the group including nonionic amphiphilic lipids, anionic amphiphilic lipids, and combinations thereof; and (ii) at least one water-soluble nonionic polymer selected from the group including homopolymers and copolymers of ethylene oxide; polyvinyl alcohols; homopolymers and copolymers of vinylpyrrolidone; homopolymers and copolymers of vinylcaprolactam; homopolymers and copolymers of polyvinyl methyl ether; neutral acrylic homopolymers and copolymers; C1-C2 alkyl celluloses and their derivatives; C1-C3 alkyl guar; C1-C3 hydroxyalkyl guar; and combinations thereof; wherein a ratio of the weight of the oily phase to the weight of the amphiphilic lipid (i) ranges from 1.2 to 10; and wherein the oily phase includes oil globules having a number-average size of less than 100 nm. The nanoemulsion obtained is preferably transparent and stable on storage. It may form a composition for topical, preferably cosmetic or dermatological compositions, pharmaceutical compositions and ophthalmological compositions.
Owner:LOREAL SA

Compositions And Methods For Treating Skin With Extract From Trametes

Compositions for treating skin containing at least one extract from the genus Trametes and at least one viscosity enhancing synthetic polymer, and methods for whitening skin, treating skin for improvement, or treating skin disorders associated with pigmentation such as uneven pigmentation, skin mottling, or age spots or other dermatological disorders such as eczema, rosacea, hyperkeratinization, and so on.
Owner:ELC MANAGEMENT LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products